# Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

> **NCT00020540** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Kidney Cancer
- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** recombinant CD40-ligand
- **BIOLOGICAL:** recombinant flt3 ligand

## Key facts

- **NCT ID:** NCT00020540
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020540, "Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00020540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*